Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.

Syage, Jack A; Green, Peter H R; Khosla, Chaitan; Adelman, Daniel C; Sealey-Voyksner, Jennifer A; Murray, Joseph A

Syage, Jack A; Green, Peter H R; Khosla, Chaitan; Adelman, Daniel C; Sealey-Voyksner, Jennifer A; Murray, Joseph A.

Afiliación

Syage JA; ImmunogenX, Newport Beach, CA, United States.
Green PHR; Celiac Disease Center, Columbia University, New York, NY, United States.
Khosla C; Stanford University, Stanford, CA, United States.
Adelman DC; Aimmune Therapeutics, Brisbane, CA, United States.
Sealey-Voyksner JA; ImmunogenX, Newport Beach, CA, United States.
Murray JA; Mayo Clinic, Rochester, MN, United States.

GastroHep ; 1(6): 293-301, 2019 Nov.

Article en En | MEDLINE | ID: mdl-32313451

Palabras clave

Celiac disease; latiglutenase; symptoms; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Idioma: En Revista: GastroHep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google